UPDATE – The M&A Class Action Firm Continues Investigating the Merger – RFP, SBTX, GBT, EVOP
22. September 2022 17:26 ET
|
Monteverde & Associates PC
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
The M&A Class Action Firm Continues Investigating the Merger – RFP, SBTX, GBT, EVOP
20. September 2022 17:27 ET
|
Monteverde & Associates PC
NEW YORK, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
SILVERBACK THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SBTX and Encourages Investors to Contact the Firm
22. Juli 2022 22:14 ET
|
Bragar Eagel & Squire
NEW YORK, July 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
SBTX TUESDAY DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Silverback Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important January 4 Deadline in Securities Class Action – SBTX
02. Januar 2022 11:00 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 02, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant...
SBTX EQUITY ALERT: NATIONALLY RANKED ROSEN LAW FIRM Encourages Silverback Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important January 4 Deadline in Securities Class Action – SBTX
28. Dezember 2021 14:15 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant...
ROSEN, A LEADING LAW FIRM, Encourages Silverback Therapeutics, Inc. Investors to Secure Counsel Before Important January 4 Deadline in Securities Class Action – SBTX
24. Dezember 2021 14:14 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 24, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant...
ROSEN, A TOP RANKED FIRM, Encourages Silverback Therapeutics, Inc. Investors to Secure Counsel Before Important January 4 Deadline in Securities Class Action – SBTX
16. Dezember 2021 18:18 ET
|
The Rosen Law Firm PA
WHY: NEW YORK, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant...
ROSEN, A TOP RANKED LAW FIRM, Encourages Silverback Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important January 4 Deadline in Securities Class Action – SBTX
07. Dezember 2021 16:15 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 07, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant...
SILVERBACK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc. and Encourages Investors to Contact the Firm
04. Dezember 2021 05:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 04, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Silverback Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SBTX
26. November 2021 18:00 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 26, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant...